您要查找的是不是：
- The positive rate of HCV Ags expression was 45% (9/20) in severe viral hepatitis, 60% (6/10) in chronic severe hepatitis, 42.9% (3/7) in subacute severe hepatitis and 0%(0/3) in acute severe hepatitis. 肝组织内HCV抗原表达阳性率45%25（9/20），其中慢性重型肝炎60%25（6/10），亚急性42.;9（3/7），急性0%25（0/3）。
- Clinical analysis of 47 cases died from acute and subacute severe hepatitis 急性和亚急性重型肝炎47例死亡病例的临床分析
- Diagnostic significance of serum immunosuppressive acidic protein level for subacute severe hepatitis 血清免疫抑酸性蛋白对亚急性重型肝炎的诊断意义
- subacute severe hepatitis 亚急性重型肝炎, 亚急性肝坏死、亚急性黄色肝萎缩
- Objective: To study the effect of prognosis of severe hepatitis. 目的：探讨影响重型肝炎预后的因素。
- Abstract: Objective: To study the effect of prognosis of severe hepatitis. 文摘:目的：探讨影响重型肝炎预后的因素。
- Analysis on 52 cases of subacute severe type hepatitis 亚急性重型肝炎52例临床分析
- This patient developed severe hepatitis with hepatic decompensation. 该例患者患了重症肝炎，肝脏失代偿。
- The severe hepatitis is often seen in viral hepatitis caused by duplicate virus and twinborn women. 两种病毒以上的感染、双胎较易发生重症肝炎。
- Objective To survey the mutuality of chronic severe hepatitis on peripheral blood cell and its results. 目的通过对慢性重型肝炎患者的外周血象分析,观察慢性重型肝炎的外周血象与其预后的相关性。
- Objective To explore the value of ABO-incompatible liver transplantation in the treatment of severe hepatitis. 结论供受体ABO血型不合肝移植可以作为抢救重症肝炎病人的选择,尤其对O型血受体疗效较好。
- Objective To evaluate the curative effect of plasma-exchange therapy for severe hepatitis in artificial liver system. 目的评价人工肝支持系统中血浆置换治疗重型肝炎的疗效。
- Methods:Analyse the 115 severe hepatitis patients complications caused by using ALSS. 方法:统计分析人工肝支持系统治疗重症肝炎115次共23人次时并发症的发生情况。
- Objective To study the effectiveness and safety of EPL in the treatment of chronic severe hepatitis, chronic hepatitis and fatty liver. 目的 应用易善力注射液治疗慢性重型肝炎、慢性肝炎和脂肪肝 ,进一步评价其安全性和疗效。
- Results: sTC concentrations were closely correlated with the Ishak score(P<0.01,r=-0.56) in the patients with chronic hepatitis B and severe hepatitis. 结果 :sTC水平与慢性乙肝及重型肝炎患者肝组织病变程度Ishak计分呈明显负相关 (P <0 0 1;r =-0 5 6)。
- BLC, HBV-DNA load and STC is valuable in predicting the trend of CHB(moderate) and the diagnosis and prognosis of severe hepatitis in time. BLC、HBV-DNA载量和STC有助于预测慢性乙肝(中度)的发展趋势,对早期诊断重型肝炎和判断预后有重要价值。
- To decrease the mortality of the patients with severe hepatitis, we should adopt rational therapeutics and prevent complications in clinical practice. 临床治疗时应采用合理的治疗方法，预防并发症，以提高重型肝炎的生存率。
- Aim To observe the clinical therapeutic effects and adverse reaction of Lipo-PGE1 in treament of chronic severe hepatitis. 目的 观察前列腺素E1脂微球载体制剂 (凯时 ,Lipo PGE1)对慢性重症肝炎的治疗作用和副作用。
- Objective To analysis the inconsistent reason of clinical diagnosis and pathology diagnosis of chronic severe hepatitis (CSH). 摘要目的分析慢性重型肝炎(CSH)临床与病理诊断不相一致的原因。
- Results In liver disease group, the levels of PLD in patients with chronic hepatitis, chronic severe hepatitis and liver cirrhosis were sta... 05或0。01),且以肝硬变升高幅度最为显著。结论PLD活性测定是一项反映慢肝病患者肝脏纤维化的良好指标之一。
